[go: up one dir, main page]

SI1613300T1 - Fotostabilizirane topiäśne formulacije ketoprofena, vsebujoäśe dva uv filtra - Google Patents

Fotostabilizirane topiäśne formulacije ketoprofena, vsebujoäśe dva uv filtra

Info

Publication number
SI1613300T1
SI1613300T1 SI200431048T SI200431048T SI1613300T1 SI 1613300 T1 SI1613300 T1 SI 1613300T1 SI 200431048 T SI200431048 T SI 200431048T SI 200431048 T SI200431048 T SI 200431048T SI 1613300 T1 SI1613300 T1 SI 1613300T1
Authority
SI
Slovenia
Prior art keywords
filters
photostabilized
topical formulations
skin
ketoprofen
Prior art date
Application number
SI200431048T
Other languages
English (en)
Inventor
Karsten Groger
Carlo Alberto Maggi
Stefano Manzini
Reinhard Schmitz
Marc Wihsmann
Original Assignee
Berlin Chemie Ag
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag
Publication of SI1613300T1 publication Critical patent/SI1613300T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SI200431048T 2003-03-18 2004-03-17 Fotostabilizirane topiäśne formulacije ketoprofena, vsebujoäśe dva uv filtra SI1613300T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000070A ITFI20030070A1 (it) 2003-03-18 2003-03-18 Formulazioni topiche stabilizzate contenenti ketoprofene
PCT/EP2004/050317 WO2004082580A2 (en) 2003-03-18 2004-03-17 Photostabilized topical formulations of ketoprofen containing two uv filters
EP04721199A EP1613300B1 (en) 2003-03-18 2004-03-17 Photostabilized topical formulations of ketoprofen containing two uv filters

Publications (1)

Publication Number Publication Date
SI1613300T1 true SI1613300T1 (sl) 2009-06-30

Family

ID=33017958

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431048T SI1613300T1 (sl) 2003-03-18 2004-03-17 Fotostabilizirane topiäśne formulacije ketoprofena, vsebujoäśe dva uv filtra

Country Status (20)

Country Link
EP (1) EP1613300B1 (sl)
KR (1) KR20060008869A (sl)
CN (1) CN1767824A (sl)
AT (1) ATE416763T1 (sl)
CY (1) CY1108869T1 (sl)
DE (1) DE602004018291D1 (sl)
DK (1) DK1613300T3 (sl)
ES (1) ES2321837T3 (sl)
IT (1) ITFI20030070A1 (sl)
MA (1) MA27669A1 (sl)
MX (1) MXPA05009902A (sl)
MY (1) MY140025A (sl)
PL (1) PL1613300T3 (sl)
PT (1) PT1613300E (sl)
RU (1) RU2340335C2 (sl)
SI (1) SI1613300T1 (sl)
TW (1) TWI327912B (sl)
UA (1) UA82871C2 (sl)
WO (1) WO2004082580A2 (sl)
ZA (1) ZA200508153B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010508289A (ja) * 2006-10-27 2010-03-18 ノーヴェン ファーマシューティカルズ インコーポレイテッド ケトプロフェン極性誘導体の経皮的送達
EP2153815A1 (en) 2008-08-05 2010-02-17 Isdin S.A. Use of urea containing compositions
EP2153814A1 (en) 2008-08-05 2010-02-17 Isdin S.A. Use of compositions comprising urea
RU2404760C1 (ru) * 2009-04-07 2010-11-27 Государственное образовательное учреждение высшего профессионального образования "Пятигорская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" Композиция - лекарственная форма нестероидного противовоспалительного средства кетопрофена для наружного применения
JP5123333B2 (ja) * 2010-01-26 2013-01-23 株式会社 資生堂 油中水型乳化日焼け止め化粧料
CN102068405A (zh) * 2010-12-16 2011-05-25 天津工业大学 一种酮洛芬凝胶及其制备方法
WO2013022410A2 (en) 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
US8822537B2 (en) * 2012-09-27 2014-09-02 Achelios Therapeutics, Inc. Topical ketoprofen composition
CN103804184B (zh) * 2014-02-14 2016-02-03 南京科胜医药科技有限公司 精氨酸酮洛芬的晶型及制备方法
RU2667465C2 (ru) * 2015-10-28 2018-09-19 Закрытое Акционерное Общество "Фармфирма "Сотекс" Фармацевтическая композиция для наружного применения, содержащая соль декскетопрофена, и способ ее получения

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
CA2093359A1 (en) * 1990-10-05 1992-04-06 Abraham Sunshine Prevention or treatment of sunburn using the s(+) isomer of ketoprofen
WO1992005768A1 (en) * 1990-10-05 1992-04-16 Analgesic Associates Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
US5185373A (en) * 1991-08-13 1993-02-09 American Home Products Corporation Inhibition of thermal degradation of ibuprofen
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
FR2804024B1 (fr) * 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
EP1269999B1 (en) * 2000-03-17 2013-05-01 Hisamitsu Pharmaceutical Co. Inc. Ultraviolet-shielding patch

Also Published As

Publication number Publication date
CY1108869T1 (el) 2014-07-02
RU2005132004A (ru) 2006-02-27
KR20060008869A (ko) 2006-01-27
ATE416763T1 (de) 2008-12-15
DK1613300T3 (da) 2009-03-09
CN1767824A (zh) 2006-05-03
MA27669A1 (fr) 2005-12-01
WO2004082580A3 (en) 2005-01-27
EP1613300B1 (en) 2008-12-10
PL1613300T3 (pl) 2009-05-29
TWI327912B (en) 2010-08-01
EP1613300A2 (en) 2006-01-11
TW200509897A (en) 2005-03-16
PT1613300E (pt) 2009-03-27
MXPA05009902A (es) 2006-03-21
UA82871C2 (en) 2008-05-26
DE602004018291D1 (de) 2009-01-22
ZA200508153B (en) 2007-10-31
RU2340335C2 (ru) 2008-12-10
ITFI20030070A1 (it) 2004-09-19
MY140025A (en) 2009-11-30
WO2004082580A2 (en) 2004-09-30
ES2321837T3 (es) 2009-06-12

Similar Documents

Publication Publication Date Title
WO2007096601A3 (en) Antimicrobial formulations comprising a quinone and a copper salt
WO2004017920A3 (en) Novel biphenyl and biphenyl-like cannabinoids
WO2005018574A3 (en) Immunostimulatory combinations and treatments
TW200505411A (en) A formulation for chemical peeling
WO2005016286A8 (en) Pyrazine modulators of cannabinoid receptors
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
NO20060416L (no) Ny anvendelse I
WO2009072007A3 (en) Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010009892A3 (en) Compositions for the treatment of pain and/or inflamation
ES2133426T3 (es) Combinaciones de productos activos fungicidas.
SI1613300T1 (sl) Fotostabilizirane topiäśne formulacije ketoprofena, vsebujoäśe dva uv filtra
ES2124983T5 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
CA2441461A1 (en) Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia
WO2003092655A3 (de) Verwendung von wirkstoffmischungen mit azelainsaure und glycyrrhetinsaure als anti-aknemittel
WO2004093816A3 (en) Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
EP2053038A4 (en) AMINO ALCOHOL DERIVATIVE AND THESE IMMUNOSUP PRESSIVES CONTAINING ACTIVE INGREDIENTS
MY139295A (en) Stabilised topical formulations containing ketoprofen
DK1666473T3 (da) Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
MXPA05008243A (es) Formulacion mejorada para agentes aclarantes de la piel.
WO2001003669A3 (en) Delivery of liposomal-encapsulated antioxidants and applications thereof
WO2008050157A3 (en) Ozonated oil formulations
WO2003061572A8 (en) Anti-inflammatory formulations
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
WO2002028388A3 (en) Use of mek1 inhibitors as protective agents against damage due to ischemia